To include your compound in the COVID-19 Resource Center, submit it here.

CoCrystal reports Phase I data for HCV candidate CC-31244

CoCrystal Pharma Inc. (OTCQB:COCP) reported data from a Phase Ia/Ib trial in 42 healthy volunteers and 15 patients with HCV genotype 1

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE